CF
Christopher Fuglesang

Christopher Fuglesang insider trades: Mirati Therapeutics (MRTX) stock buys and sales

Mirati Therapeutics Last trade Aug 11, 2023 9 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2017
2
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christopher reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 11, 2023MRTX↑ Buy$33.4M
Aug 11, 2023MRTX↑ Buy$33.4M
Aug 11, 2023MRTX↑ Buy$1.6M
Aug 11, 2023MRTX↑ Buy$1.6M
Mar 5, 2021MRTX↓ Sell$72.5M
Oct 30, 2020MRTX↓ Sell$80.8M
Jul 21, 2020PAND↑ Buy$13.0M
Jan 6, 2017MRTX↑ Buy$1.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Christopher Fuglesang's insider trades

Christopher Fuglesang is an insider at Mirati Therapeutics (MRTX). Since Jan 6, 2017, Christopher has reported 6 open-market purchases worth $84.6M and 2 sales worth $153.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (3 filings), shares returned to the company (2 filings), other transactions (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.